HeartSciences Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $HSCS in the last 30 days.
See all $HSCS insider activity →China SXT Pharmaceuticals (SXTC) rose 7% after terminating an additional purchase right tied to its recent offering. Imunon (IMNN) surged 18% following a deal to sell ThermoDox rights, potentially receiving $16.5M in milestone payments. HeartSciences (HSCS) gained 13% after filing a proxy statement for a proposed merger with Fortitude Mining, creating a digital asset mining platform.
HeartSciences Inc. (HSCS) scheduled a Nov. 19, 2026 shareholder vote for its all-stock merger with Fortitude Mining. The combined entity, pending approvals, will trade on Nasdaq as TUDE. The merger aims to transform HSCS into a crypto mining platform.
HeartSciences Inc. (HSCS) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 HeartSciences Receives FDA 510(k) Clearance for its MyoVista ® wav ECG TM Device Southlake, TX, October 6, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focuse
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning HSCS (HeartSciences Inc.). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.
Recent HSCS coverage spans corporate actions, market movers and regulation.
Deal announcement fuels buying interest.
The merger vote creates a binary catalyst; approval could boost the stock, rejection may cause a sell‑off.
The clearance adds a tangible asset to HeartSciences' pipeline, creating upside potential if the device is later commercialized.
The clearance removes a regulatory hurdle but the company has no timeline to commercialize, creating uncertainty.
Progress on the SPAC merger keeps HSCS in focus; no new terms disclosed beyond the ongoing combination.
AlphAI scores every news story that mentions HSCS with an AI model for sentiment and relevance, and aggregates insider trades from HeartSciences Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
China SXT Pharmaceuticals (SXTC) rose 7% after terminating an additional purchase right tied to its recent offering. Imunon (IMNN) surged 18% following a deal to sell ThermoDox rights, potentially receiving $16.5M in milestone payments. HeartSciences (HSCS) gained 13% after filing a proxy statement for a proposed merger with Fortitude Mining, creating a digital asset mining platform.
2 min readHeartSciences Inc. (HSCS) scheduled a Nov. 19, 2026 shareholder vote for its all-stock merger with Fortitude Mining. The combined entity, pending approvals, will trade on Nasdaq as TUDE. The merger aims to transform HSCS into a crypto mining platform.
1 min readHeartSciences Inc. (HSCS) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 HeartSciences Receives FDA 510(k) Clearance for its MyoVista ® wav ECG TM Device Southlake, TX, October 6, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focuse
2 min readHeartSciences Inc. (HSCS) received FDA 510(k) clearance for its MyoVista® wavECGTM device as a 12-lead resting electrocardiograph. The clearance does not include an AI-ECG algorithm. The company plans to evaluate options for the device and its intellectual property. HeartSciences also announced progress in its proposed business combination with Fortitude Mining Holdings, expected to close in Q4 2026, subject to shareholder approval.
2 min readFortitude Mining Holdings' subsidiary agreed to a non-binding letter of intent with Bitmain for up to $100M of next-gen Zcash mining equipment, shipping in Q2 2027. Fortitude also increased its credit facility with Digital Currency Group from $50M to $70M, with $42.7M remaining. The company plans to draw $20M this week, funded by DCG in ZEC. Fortitude operates 4.7 GSol/s of hashrate and is pursuing a business combination with HeartSciences Inc. (HSCS).
2 min readHeartSciences amended its loan agreement with Front Range Ventures, extending the maturity to the earlier of two days after the Fortitude Mining combination closes or January 29, 2027. The company can prepay at least $50,000 at any time, with accrued interest due by the new maturity date. The amendment aligns repayment with the pending merger.
1 min readHeartSciences Inc. (HSCS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. As previously reported, HeartSciences Inc. (the “Company”) entered into a Loan and Security Agreement on April 24, 2020 (the “Original Loan Agreement”), as amended by Amendment No. 1 to the Loan and Security Agreement, dated S
1 min readFortitude Mining, a Zcash-focused company, increased its credit facility with DCG to $50M, with $31M available. It plans to draw $31M in ZEC to fund hardware and infrastructure expansion. Fortitude aims to list on Nasdaq via a merger with HeartSciences (HSCS).
2 min readSeveral biotech stocks reached 52-week highs on September 18, 2026. Vogenx (VOGX) shares surged to $38.41, driven by positive clinical trial results. HeartSciences (HSCS) rose 7% to $5.21, while HeartFlow (HTFL) increased 2% to $52.22. Freenome (FRNM) gained 5% to $17.25, and Halozyme (HALO) hit $112.66 after announcing a $1.3B offering.
4 min readHeartSciences Inc. (HSCS) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 PRESS RELEASE Fortitude Appoints Jaime Leverton as Chief Executive Officer Former Hut 8 CEO to Lead Fortitude as the Zcash-Focused, Vertically-Integrated Mining Platform Advances Toward the Public Markets; Andrea Childs to Transition to Chief Operating Officer Fairpo
2 min read
